6 months ago
KWS SAAT SE & Co. KGaA: KWS reports on successful fiscal year 2021/2022 and expects further growth
marketscreener.com
7 months ago
Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane)
Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure
Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million
Heidelberger Druckmaschinen : HEIDELBERG makes successful start to 2022/23 financial year – sales and earnings increase in Q1
8 months ago
Alnylam Reports Positive Topline Results from APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy
Heidelberger Druckmaschinen : Druckhaus Müller OHG boosts postpress productivity with state-of-the-art Stahlfolder technology from HEIDELBERG
9 months ago
Blueprint Medicines Reports Continued Progress Toward Goal of Transforming Treatment of Systemic Mastocytosis
Heidelberger Druckmaschinen : HEIDELBERG expecting further profitable growth in financial year 2022/23 despite major uncertainties